Cargando…

Tracking of In-111-labeled human umbilical tissue-derived cells (hUTC) in a rat model of cerebral ischemia using SPECT imaging

BACKGROUND: In order to increase understanding of how infused cells work, it becomes important to track their initial movement, localization, and engraftment efficiency following transplantation. However, the available in vivo cell tracking techniques are suboptimal. The study objective was to deter...

Descripción completa

Detalles Bibliográficos
Autores principales: Arbab, Ali S, Thiffault, Christine, Navia, Bradford, Victor, Stephen J, Hong, Klaudyne, Zhang, Li, Jiang, Quan, Varma, Nadimpalli RS, Iskander, ASM, Chopp, Michael
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2012
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3538050/
https://www.ncbi.nlm.nih.gov/pubmed/23217090
http://dx.doi.org/10.1186/1471-2342-12-33
_version_ 1782254923439669248
author Arbab, Ali S
Thiffault, Christine
Navia, Bradford
Victor, Stephen J
Hong, Klaudyne
Zhang, Li
Jiang, Quan
Varma, Nadimpalli RS
Iskander, ASM
Chopp, Michael
author_facet Arbab, Ali S
Thiffault, Christine
Navia, Bradford
Victor, Stephen J
Hong, Klaudyne
Zhang, Li
Jiang, Quan
Varma, Nadimpalli RS
Iskander, ASM
Chopp, Michael
author_sort Arbab, Ali S
collection PubMed
description BACKGROUND: In order to increase understanding of how infused cells work, it becomes important to track their initial movement, localization, and engraftment efficiency following transplantation. However, the available in vivo cell tracking techniques are suboptimal. The study objective was to determine the biodistribution of intravenously administered Indium-111 (In-111) oxine labeled human umbilical tissue-derived cells (hUTC) in a rat model of transient middle cerebral occlusion (tMCAo) using single photon emission computed tomography (SPECT). METHODS: Rats received 3 million In-111 labeled hUTC (i.v.) 48 hrs after tMCAo. Following the administration of either hUTC or equivalent dose of In-111-oxine (18.5 MBq), animals underwent SPECT imaging on days 0, 1, and 3. Radioactivity in various organs as well as in the stroke area and contralateral hemisphere was determined, decay corrected and normalized to the total (whole body including head) radioactivity on day 0. Immunohistochemical analysis was also performed to confirm the beneficial effects of hUTC on vascular and synaptic density, and apoptosis. RESULTS: Most of the radioactivity (43.36±23.07% on day 0) trafficked to the lungs immediately following IV administration of In-111 labeled hUTC (day 0) and decreased drastically to 8.81±7.75 and 4.01±4.52% on days 1 and 3 post-injection, respectively. In contrast, radioactivity measured in the lung of animals that received In-111-oxine alone remained relatively unchanged from day 0 to day 1 (18.38±5.45% at day 0 to 12.59±5.94%) and decreased to 8.34±4.25% on day 3. Significantly higher radioactivity was observed in stroke areas of animals that received In-111 labeled hUTC indicating the presence of cells at the site of injury representing approximately 1% of total administered dose. In addition, there was significant increase in vascular and synaptophysin immunoreactivity in stroke areas of rats that received In-111 labeled hUTC. CONCLUSIONS: The present studies showed the tracking of In-111 labeled hUTC to the sites of stroke in a rat model of tMCAo using SPECT. Animals treated with In-111 labeled hUTC showed histological improvements, with higher vascular and synaptic densities observed in the ischemic boundary zone (IBZ).
format Online
Article
Text
id pubmed-3538050
institution National Center for Biotechnology Information
language English
publishDate 2012
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-35380502013-01-10 Tracking of In-111-labeled human umbilical tissue-derived cells (hUTC) in a rat model of cerebral ischemia using SPECT imaging Arbab, Ali S Thiffault, Christine Navia, Bradford Victor, Stephen J Hong, Klaudyne Zhang, Li Jiang, Quan Varma, Nadimpalli RS Iskander, ASM Chopp, Michael BMC Med Imaging Research Article BACKGROUND: In order to increase understanding of how infused cells work, it becomes important to track their initial movement, localization, and engraftment efficiency following transplantation. However, the available in vivo cell tracking techniques are suboptimal. The study objective was to determine the biodistribution of intravenously administered Indium-111 (In-111) oxine labeled human umbilical tissue-derived cells (hUTC) in a rat model of transient middle cerebral occlusion (tMCAo) using single photon emission computed tomography (SPECT). METHODS: Rats received 3 million In-111 labeled hUTC (i.v.) 48 hrs after tMCAo. Following the administration of either hUTC or equivalent dose of In-111-oxine (18.5 MBq), animals underwent SPECT imaging on days 0, 1, and 3. Radioactivity in various organs as well as in the stroke area and contralateral hemisphere was determined, decay corrected and normalized to the total (whole body including head) radioactivity on day 0. Immunohistochemical analysis was also performed to confirm the beneficial effects of hUTC on vascular and synaptic density, and apoptosis. RESULTS: Most of the radioactivity (43.36±23.07% on day 0) trafficked to the lungs immediately following IV administration of In-111 labeled hUTC (day 0) and decreased drastically to 8.81±7.75 and 4.01±4.52% on days 1 and 3 post-injection, respectively. In contrast, radioactivity measured in the lung of animals that received In-111-oxine alone remained relatively unchanged from day 0 to day 1 (18.38±5.45% at day 0 to 12.59±5.94%) and decreased to 8.34±4.25% on day 3. Significantly higher radioactivity was observed in stroke areas of animals that received In-111 labeled hUTC indicating the presence of cells at the site of injury representing approximately 1% of total administered dose. In addition, there was significant increase in vascular and synaptophysin immunoreactivity in stroke areas of rats that received In-111 labeled hUTC. CONCLUSIONS: The present studies showed the tracking of In-111 labeled hUTC to the sites of stroke in a rat model of tMCAo using SPECT. Animals treated with In-111 labeled hUTC showed histological improvements, with higher vascular and synaptic densities observed in the ischemic boundary zone (IBZ). BioMed Central 2012-12-06 /pmc/articles/PMC3538050/ /pubmed/23217090 http://dx.doi.org/10.1186/1471-2342-12-33 Text en Copyright ©2012 Arbab et al.; licensee BioMed Central Ltd. http://creativecommons.org/licenses/by/2.0 This is an Open Access article distributed under the terms of the Creative Commons Attribution License ( http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Research Article
Arbab, Ali S
Thiffault, Christine
Navia, Bradford
Victor, Stephen J
Hong, Klaudyne
Zhang, Li
Jiang, Quan
Varma, Nadimpalli RS
Iskander, ASM
Chopp, Michael
Tracking of In-111-labeled human umbilical tissue-derived cells (hUTC) in a rat model of cerebral ischemia using SPECT imaging
title Tracking of In-111-labeled human umbilical tissue-derived cells (hUTC) in a rat model of cerebral ischemia using SPECT imaging
title_full Tracking of In-111-labeled human umbilical tissue-derived cells (hUTC) in a rat model of cerebral ischemia using SPECT imaging
title_fullStr Tracking of In-111-labeled human umbilical tissue-derived cells (hUTC) in a rat model of cerebral ischemia using SPECT imaging
title_full_unstemmed Tracking of In-111-labeled human umbilical tissue-derived cells (hUTC) in a rat model of cerebral ischemia using SPECT imaging
title_short Tracking of In-111-labeled human umbilical tissue-derived cells (hUTC) in a rat model of cerebral ischemia using SPECT imaging
title_sort tracking of in-111-labeled human umbilical tissue-derived cells (hutc) in a rat model of cerebral ischemia using spect imaging
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3538050/
https://www.ncbi.nlm.nih.gov/pubmed/23217090
http://dx.doi.org/10.1186/1471-2342-12-33
work_keys_str_mv AT arbabalis trackingofin111labeledhumanumbilicaltissuederivedcellshutcinaratmodelofcerebralischemiausingspectimaging
AT thiffaultchristine trackingofin111labeledhumanumbilicaltissuederivedcellshutcinaratmodelofcerebralischemiausingspectimaging
AT naviabradford trackingofin111labeledhumanumbilicaltissuederivedcellshutcinaratmodelofcerebralischemiausingspectimaging
AT victorstephenj trackingofin111labeledhumanumbilicaltissuederivedcellshutcinaratmodelofcerebralischemiausingspectimaging
AT hongklaudyne trackingofin111labeledhumanumbilicaltissuederivedcellshutcinaratmodelofcerebralischemiausingspectimaging
AT zhangli trackingofin111labeledhumanumbilicaltissuederivedcellshutcinaratmodelofcerebralischemiausingspectimaging
AT jiangquan trackingofin111labeledhumanumbilicaltissuederivedcellshutcinaratmodelofcerebralischemiausingspectimaging
AT varmanadimpallirs trackingofin111labeledhumanumbilicaltissuederivedcellshutcinaratmodelofcerebralischemiausingspectimaging
AT iskanderasm trackingofin111labeledhumanumbilicaltissuederivedcellshutcinaratmodelofcerebralischemiausingspectimaging
AT choppmichael trackingofin111labeledhumanumbilicaltissuederivedcellshutcinaratmodelofcerebralischemiausingspectimaging